[1]王哲,孙东.万古霉素治疗小儿骨髓炎致DRESS综合征1例[J].临床小儿外科杂志,2020,19(10):957-960.[doi:10.3969/j.issn.1671-6353.2020.10.018]
点击复制

万古霉素治疗小儿骨髓炎致DRESS综合征1例

参考文献/References:

1 Bocquet H,Bagot M,Roujeau JC,et al.Drug-induced pseudolymphoma and drug hypersensitivity syndrome(drug rash with eosinophilia and systemic symptoms:DRESS)[J].Semin Cutan Med Surg,1996,15(4):250-257.DOI:10.1016/S1085-5629(96)80038-1.
2 Chen YC,Cho YT,Chang CY,et al.Drug reaction with eosinophilia and systemic symptoms:a drug-induced hypersensitivity syndrome with variable clinical features[J].Dermatol Sin,2013,31(4):196-204.DOI:10.1016/j.dsi.2013.09.006.
3 Hirahara K,Kano Y,Mitsuyama Y,et al.Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions[J].Clin Exp Dermatol,2010,35(8):863-868.DOI:10.1111/j.1365-2230.2010.03820.x.
4 Olivia W,Mohamed H,John A,et al.Case report:atypical presentation of vancomycin induced DRESS syndrome:a case report and review of the literature[J].BMC Pulmonary Medicine,2017,17(1):217-223.DOI:10.1186/s12890-017-0564-6.
5 Hiransuthikul A,Rattananupong T,Klaewsongkram J,et al.Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms(DIHS/DRESS):11 years retrospective study in Thailand[J].Allergol Int,2016,65(4):432-438.DOI:10.1016/j.alit.2016.04.001.
6 Choquet-Kastylevsky G,Intrator L,Chenal C,et al.Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome[J].Br J Dermatol,1998,139(6):1026-1032. DOI:10.1046/j.1365-2133.1998.02559.x.
7 Kardaun SH,Sidoroff A,Valeyrie-Allanore L,et al.Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms:Does a DRESS syndrome really exist?[J].Br J Dermatol,2007,156(3):609-611.DOI:10.1111/j.1365-2133.2006.07704.x
8 Groh M,Pagnoux C,Baldini C,et al.Eosinophilic granulomatosis with polyangiitis(Churg-Strauss)(EGPA)consensus task force recommendations for evaluation and management[J].Eur J Intern Med,2015,26(7):545-553.DOI:10.1016/j.ejim.2015.04.022.
9 Gotlib J.World Health Organization-defined eosinophilic disorders:2017 update on diagnosis,risk stratification,and management[J].Am J Hematol,2017,92(11):1243-1259.DOI:10.1002/ajh.24880.
10 Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Pediatrics,2004,114(6):1708-1733.DOI:10.1542/peds.2004-2182.
11 Funck-Brentano E,Duong TA,Bouvresse S,et al.Therapeutic management of DRESS:a retrospective study of 38 cases[J].J Am Acad Dermatol,2015,72(2):246-252. DOI:10.1016/J.JAAD.2014.10.032.
12 Criado PR,Avancini J,Santi CG,et al.Drug reaction with eosinophilia and systemic symptoms(DRESS):a complex interaction of drugs,viruses and the immune system[J].Isr Med Assoc J,2012,14(9):577-582.

备注/Memo

收稿日期:2018-12-15。
通讯作者:王克来,Email:wangkelai@yeah.cn

更新日期/Last Update: 2020-10-28